Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1989 2
1990 8
1991 4
1992 6
1993 9
1994 11
1995 8
1996 16
1997 6
1998 10
1999 23
2000 19
2001 32
2002 21
2003 37
2004 36
2005 30
2006 26
2007 48
2008 36
2009 63
2010 85
2011 62
2012 72
2013 73
2014 68
2015 84
2016 109
2017 131
2018 139
2019 162
2020 165
2021 239
2022 200
2023 213
2024 224
2025 324
2026 2

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

2,499 results

Results by year

Filters applied: . Clear all
Page 1
Alzheimer Disease as a Clinical-Biological Construct-An International Working Group Recommendation.
Dubois B, Villain N, Schneider L, Fox N, Campbell N, Galasko D, Kivipelto M, Jessen F, Hanseeuw B, Boada M, Barkhof F, Nordberg A, Froelich L, Waldemar G, Frederiksen KS, Padovani A, Planche V, Rowe C, Bejanin A, Ibanez A, Cappa S, Caramelli P, Nitrini R, Allegri R, Slachevsky A, de Souza LC, Bozoki A, Widera E, Blennow K, Ritchie C, Agronin M, Lopera F, Delano-Wood L, Bombois S, Levy R, Thambisetty M, Georges J, Jones DT, Lavretsky H, Schott J, Gatchel J, Swantek S, Newhouse P, Feldman HH, Frisoni GB. Dubois B, et al. Among authors: blennow k. JAMA Neurol. 2024 Dec 1;81(12):1304-1311. doi: 10.1001/jamaneurol.2024.3770. JAMA Neurol. 2024. PMID: 39483064 Free PMC article.
Blood Biomarkers to Detect Alzheimer Disease in Primary Care and Secondary Care.
Palmqvist S, Tideman P, Mattsson-Carlgren N, Schindler SE, Smith R, Ossenkoppele R, Calling S, West T, Monane M, Verghese PB, Braunstein JB, Blennow K, Janelidze S, Stomrud E, Salvadó G, Hansson O. Palmqvist S, et al. Among authors: blennow k. JAMA. 2024 Oct 15;332(15):1245-1257. doi: 10.1001/jama.2024.13855. JAMA. 2024. PMID: 39068545 Free PMC article.
Diagnostic Accuracy of a Plasma Phosphorylated Tau 217 Immunoassay for Alzheimer Disease Pathology.
Ashton NJ, Brum WS, Di Molfetta G, Benedet AL, Arslan B, Jonaitis E, Langhough RE, Cody K, Wilson R, Carlsson CM, Vanmechelen E, Montoliu-Gaya L, Lantero-Rodriguez J, Rahmouni N, Tissot C, Stevenson J, Servaes S, Therriault J, Pascoal T, Lleó A, Alcolea D, Fortea J, Rosa-Neto P, Johnson S, Jeromin A, Blennow K, Zetterberg H. Ashton NJ, et al. Among authors: blennow k. JAMA Neurol. 2024 Mar 1;81(3):255-263. doi: 10.1001/jamaneurol.2023.5319. JAMA Neurol. 2024. PMID: 38252443 Free PMC article.
Neurofilaments as biomarkers in neurological disorders - towards clinical application.
Khalil M, Teunissen CE, Lehmann S, Otto M, Piehl F, Ziemssen T, Bittner S, Sormani MP, Gattringer T, Abu-Rumeileh S, Thebault S, Abdelhak A, Green A, Benkert P, Kappos L, Comabella M, Tumani H, Freedman MS, Petzold A, Blennow K, Zetterberg H, Leppert D, Kuhle J. Khalil M, et al. Among authors: blennow k. Nat Rev Neurol. 2024 May;20(5):269-287. doi: 10.1038/s41582-024-00955-x. Epub 2024 Apr 12. Nat Rev Neurol. 2024. PMID: 38609644 Review.
Two Phase 3 Trials of Gantenerumab in Early Alzheimer's Disease.
Bateman RJ, Smith J, Donohue MC, Delmar P, Abbas R, Salloway S, Wojtowicz J, Blennow K, Bittner T, Black SE, Klein G, Boada M, Grimmer T, Tamaoka A, Perry RJ, Turner RS, Watson D, Woodward M, Thanasopoulou A, Lane C, Baudler M, Fox NC, Cummings JL, Fontoura P, Doody RS; GRADUATE I and II Investigators and the Gantenerumab Study Group. Bateman RJ, et al. Among authors: blennow k. N Engl J Med. 2023 Nov 16;389(20):1862-1876. doi: 10.1056/NEJMoa2304430. N Engl J Med. 2023. PMID: 37966285 Free PMC article. Clinical Trial.
Considerations in the clinical use of amyloid PET and CSF biomarkers for Alzheimer's disease.
Leuzy A, Bollack A, Pellegrino D, Teunissen CE, La Joie R, Rabinovici GD, Franzmeier N, Johnson K, Barkhof F, Shaw LM, Arkhipenko A, Schindler SE, Honig LS, Moscoso Rial A, Schöll M, Zetterberg H, Blennow K, Hansson O, Farrar G. Leuzy A, et al. Among authors: blennow k. Alzheimers Dement. 2025 Mar;21(3):e14528. doi: 10.1002/alz.14528. Alzheimers Dement. 2025. PMID: 40042435 Free PMC article. Review.
Biomarkers.
Zetterberg H, Blennow K. Zetterberg H, et al. Among authors: blennow k. Alzheimers Dement. 2025 Dec;21 Suppl 2(Suppl 2):e099493. doi: 10.1002/alz70856_099493. Alzheimers Dement. 2025. PMID: 41445371 Free PMC article. Review.
Biomarkers.
Yun J, Shin D, Lee EH, Kim JP, Ham H, Gu Y, Kang SH, Kim HJ, Na DL, Kim CH, Kim KW, Kim SE, Kim Y, Kim J, Jung NY, Kim YJ, Cho SH, Zetterberg H, Blennow K, Gonzalez-Ortiz F, Ashton N, Seo SW, Jang H; K‐ROAD study groups. Yun J, et al. Among authors: blennow k. Alzheimers Dement. 2025 Dec;21 Suppl 2(Suppl 2):e102727. doi: 10.1002/alz70856_102727. Alzheimers Dement. 2025. PMID: 41442640 Free PMC article.
Biomarkers.
Delaby C, Ladang A, Yriarte J, Zecca C, Logroscino G, Koertvelyessy P, Tumani H, Parchi P, Quadrio I, Hart M, Olsen DA, Alcolea D, Blennow K, Fortea J, Lleó A, Algeciras-Schimnich A, Ayrignac X, Bedel A, Santos GAA, Borelli WV, Amar EB, Baldeiras I, Bigot-Corbel E, Bjerke M, Perez MC, Casoli T, Chabrashvili T, Chapman MD, Cusato J, Dursun E, Fourier A, Galimberti D, Gezen-Ak D, Gordon BA, Gouju J, de Las Heras Florez S, Sánchez JJH, Herwerth M, Imperiale D, Kaczorowski F, Kasuga K, Keshavan A, Khalil M, Kuhle J, Leithner C, Lewczuk P, Letournel F, Tsolaki M, Giuffrè GM, Blanc MC, Mroszko B, Rodríguez-Álvarez J, Musso G, Kulczynska-Przybik A, Nogueira L, Paquet C, Baiardi S, Gaetani L, Parnetti L, Garay RP, Poesen K, Quillard-Muraine M, Borja ER, Schraen-Maschke S, Terracciano D, Bachhuber F, Halbgebauer S, Tzartos S, Tzartos J, Unterwalder N, Vermunt L, Wellington CL, Zetterberg H, Teunissen CE, Lehmann S. Delaby C, et al. Among authors: blennow k. Alzheimers Dement. 2025 Dec;21 Suppl 2(Suppl 2):e104274. doi: 10.1002/alz70856_104274. Alzheimers Dement. 2025. PMID: 41443588 Free PMC article.
Biomarkers.
Rodríguez-Fernández B, Escalante AG, Genius P, Evans TE, Ortiz-Romero P, Minguillón C, Kollmorgen G, Ashton NJ, Zetterberg H, Blennow K, Gispert JD, Navarro A, Suarez-Calvet M, Sala-Vila A, Crous-Bou M, Vilor-Tejedor N. Rodríguez-Fernández B, et al. Among authors: blennow k. Alzheimers Dement. 2025 Dec;21 Suppl 2(Suppl 2):e098828. doi: 10.1002/alz70856_098828. Alzheimers Dement. 2025. PMID: 41441797 Free PMC article.
2,499 results